The company will use the funds to work in collaboration with George Mason University to apply its technology to detecting viruses in non-invasive samples.
The FDA granted Abbott Emergency Use Authorization for the assay in serum, plasma, and urine in November.
A study by Brazilian researchers identified cellular processes affected by the virus that could explain the brain malformations associated with the disease.
The firm said that it is on track to seek FDA approval for a liquid cytology solution early this year.
The biggest biology stories of the year include the Zika virus, CRISPR, and more, according to Wired.
Mick Mulvaney, President-elect Donald Trump's choice to run the White House budget office, has wondered whether government-funded research is necessary, Vox reports.
There are a number of efforts underway to develop DNA vaccines for diseases like Zika, according to the Wall Street Journal.
Hologic CEO Steve MacMillan said that the deal is so compelling that the firm needed to do it now.
The CDC noted that if the test yields a negative RNA NAT result, clinicians should then analyze patient serum using an IgM antibody test.
Some voters in Florida are considering a ballot question about using genetically modified mosquitos to halt the spread of disease.
In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.
Some people who harbor genetic variants associated with disease show no signs and may give insight into the continuum of symptoms, Spectrum reports.
Some 57 snow monkeys at a Japanese zoo were found to be rhesus macaque hybrids, which are banned in Japan.
British researchers say they've been removed from EU grant applications, according to the Guardian.